{"id":30626,"date":"2024-11-11T09:43:35","date_gmt":"2024-11-11T13:43:35","guid":{"rendered":"https:\/\/cdtrp.ca\/pediatric-transplant-symposium-pleins-feux-sur-la-2e-session\/"},"modified":"2024-11-11T09:43:47","modified_gmt":"2024-11-11T13:43:47","slug":"pediatric-transplant-symposium-pleins-feux-sur-la-2e-session","status":"publish","type":"post","link":"https:\/\/cdtrp.ca\/fr\/pediatric-transplant-symposium-pleins-feux-sur-la-2e-session\/","title":{"rendered":"Pediatric Transplant Symposium – Pleins feux sur la 2e Session"},"content":{"rendered":"

<\/a><\/span><\/div>
<\/div>

Pediatric Transplant Symposium<\/strong><\/h4>\n

La Dre Lorraine Hamiwka est heureuse d\u2019organiser le tout premier , est heureuse d\u2019organiser le tout premier symposium multidisciplinaire et multi-organes sur la transplantation p\u00e9diatrique, qui se tiendra en format hybride<\/strong>, avec un volet en personne \u00e0 Calgary, en Alberta<\/strong>.<\/p>\n

Ce symposium vise \u00e0 mettre en \u00e9vidence les opportunit\u00e9s actuelles et \u00e9mergentes pour mettre en \u0153uvre les derni\u00e8res preuves en mati\u00e8re de recherche sur la transplantation p\u00e9diatrique en Alberta et \u00e0 l\u2019international. Il comprendra \u00e9galement un conf\u00e9rencier principal, des sessions suppl\u00e9mentaires, des tables rondes, des sessions interactives et des moments d\u00e9di\u00e9s au r\u00e9seautage. Ce programme rassemble des chercheurs de renomm\u00e9e mondiale (d\u2019Alberta, du Canada et de l\u2019international), des professionnels de la sant\u00e9, ainsi que des partenaires de recherche impliquant des patients, des familles et des donneurs, qui sont \u00e0 la pointe de la recherche sur la transplantation p\u00e9diatrique. Ce forum mettra en \u00e9vidence les principaux d\u00e9veloppements scientifiques qui ont permis d\u2019am\u00e9liorer les soins, le traitement et le bien-\u00eatre des patients et de leurs familles avant, pendant et apr\u00e8s une greffe d\u2019organe. Cet \u00e9v\u00e9nement est gratuit.<\/p>\n<\/div>

<\/div>
<\/i>Visitez le site web<\/span><\/a><\/div><\/div><\/div><\/div><\/div>
<\/a><\/span><\/div><\/div>
<\/div>
<\/div>
<\/div>

Session 2: Into the 21st century: Updates on Novel Diagnostics<\/em><\/strong>\u00a0(10:40 – 12:00)<\/h4>\n
Mod\u00e9r\u00e9e par le Dr. Steven Greenway, cette session explorera les avanc\u00e9es significatives dans le domaine du diagnostic de la transplantation. Le Dr. Phil Halloran lancera la session avec une pr\u00e9sentation intitul\u00e9e \u00ab\u00a0Refining Pathology Using Genetic Transcript Analysis.<\/strong><\/em>\u00a0\u00bb Ensuite, la Dre. Seema Mital pr\u00e9sentera \u00ab\u00a0Precision Medicine in Transplantation Care.<\/strong><\/em>\u00a0\u00bb Le Dr. Tom Blydt-Hansen cl\u00f4turera cette session avec une pr\u00e9sentation intitul\u00e9e \u00ab\u00a0Non-invasive Monitoring of Graft Rejection.<\/strong><\/em>\u00a0\u00bb transplant patients.<\/h6>\n
La session se terminera par une s\u00e9ance de questions-r\u00e9ponses (11h 40 \u2013 12 h 00), permettant aux participants d\u2019interagir avec les conf\u00e9renciers et d\u2019approfondir leur compr\u00e9hension des soins \u00e9quitables pour les patients greff\u00e9s p\u00e9diatriques.<\/h6>\n
Inscrivez-vous ci-dessous pour vous assurer de participer \u00e0 ces discussions \u00e9clairantes!<\/h6>\n<\/div>
<\/div>
<\/div>
<\/div>
<\/i>INSCRIPTION<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div><\/div>
\"Image<\/a><\/span><\/div><\/div><\/div>

\u00c0 propos de Dr. Phil Halloran<\/strong><\/p>\n

\n
Dr. Philip F. Halloran earned his MD from the University of Toronto and a PhD in immunogenetics from the University of London. He began his career at the University of Toronto\u2019s Toronto General Hospital and later became Director of Nephrology at the University of Alberta. Dr. Halloran is a founding editor of the American Journal of Transplantation and chaired the board of the Roche Organ Transplantation Research Foundation in Switzerland. Now a Distinguished Professor of Medicine at the University of Alberta, his research focuses on the molecular mechanisms of organ rejection and injury, developing diagnostic tools to improve transplant care. He has published 411 original peer-reviewed papers and has trained many fellows now on university faculties around the world.<\/div>\n
<\/div>\n
His Molecular Microscope\u00ae Diagnostic System (MMDx) uses microarrays to assess organ transplant biopsies. Dr. Halloran\u2019s program integrates gene-wide measurements with machine learning to link molecular changes to disease states, fostering collaborations across 80 research centers worldwide. A fellow of the Royal Society of Canada and an officer of the Order of Canada, Dr. Halloran has received numerous awards, including the J. Gordin Kaplan Award for Excellence in Research and the Prix Galien Canada Research Award. His achievements also include lifetime honors from the American Society of Transplantation and international recognition from institutions in France and the Czech Republic.<\/div>\n<\/div>\n<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Image<\/a><\/span><\/div><\/div><\/div>

\u00c0 propos de Dre. Seema Mital<\/strong><\/p>\n

Dr. Seema Mital is a Staff Cardiologist & the Head of Cardiovascular Research at the Hospital for Sick Children (SickKids), Professor of Paediatrics at the University of Toronto, and a Senior Scientist at the SickKids Research Institute. She is also the Heart and Stroke Foundation of Canada Chair of Cardiovascular Science, and the Scientific Co-Lead of the Ted Rogers Centre for Heart Research. She leads the Cardiac Precision Medicine program at SickKids that leverages genomics, stem cells, AI and digital technology to model disease, test therapies, and implement precision-focused decision support tools. Dr. Mital established the SickKids Heart Centre Biobank, a multi-centre biorepository for childhood onset heart disease as well as a pan-Canadian Transplant Biobank Registry. She leads the ERAPerMed\/CIHR funded PROCEED network for Personalized Genomics in congenital heart disease, the multi-centre international Precision Medicine in Cardiomyopathy (PRIMaCY) network, the CIHR-funded multi-centre INSERT-HCM study, and co-leads the CIHR-funded Precision Medicine for Heart Failure in the Young (PRIORITY) project of the Canadian Heart Function Alliance. She led the CDTRP funded pan-Canadian Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression to ImproVe Efficacy (POSITIVE Study).<\/div>\n<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Image<\/a><\/span><\/div><\/div><\/div>

\u00c0 propos de Dr. Tom Blydt-Hansen<\/strong><\/p>\n

Dr. Tom Blydt-Hansen completed his MD at McGill University, and his Pediatric and Nephrology specialization at the Montreal Children’s Hospital, followed by further specialization in transplantation at the University of California, Los Angeles. He began his Nephrology career at the University of Manitoba in 2001, where he was Division Head of Nephrology from 2005-2014. He then moved to BC Children\u2019s Hospital in 2014, where he is Director of the Multi Organ Transplant Program and Senior Scientist at the BCCH Research Institute. He is a past-President of the Canadian Society of Transplantation, a Board member of the NAPRTCS Registry, and collaborating with Canadian Blood Services to establish national Class II matching for pediatric transplant recipients. His research program is focused on identification and development of relevant non-invasive urine biomarkers of allograft injury in pediatric kidney transplant recipients using metabolomic and proteomic methods. He is also engaged in several collaborations to identify urinary biomarkers (metabolomics) associated with chronic kidney disease, acute kidney injury, cisplatin toxicity, type 2 diabetes and cisplatin nephrotoxicity.<\/div>\n<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div>
\"Image<\/a><\/span><\/div><\/div><\/div>

\u00c0 propos de Dr. Steven Greenway<\/strong><\/p>\n

\n
Steven Greenway is a pediatric cardiologist and translational researcher in Calgary whose practice includes managing children with heart failure and post-heart transplantation.<\/div>\n<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":8,"featured_media":30585,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[81,37],"tags":[],"class_list":["post-30626","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-vedette","category-non-classifiee"],"_links":{"self":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/30626"}],"collection":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/comments?post=30626"}],"version-history":[{"count":5,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/30626\/revisions"}],"predecessor-version":[{"id":30631,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/posts\/30626\/revisions\/30631"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media\/30585"}],"wp:attachment":[{"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/media?parent=30626"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/categories?post=30626"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cdtrp.ca\/fr\/wp-json\/wp\/v2\/tags?post=30626"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}